U.S. Online Retail and Ecommerce Stock News

NYSE:CTRI
NYSE:CTRIConstruction

Did Centuri’s US$300 Million in New Energy Contracts Just Shift Centuri Holdings' (CTRI) Investment Narrative?

In May 2026, Centuri Holdings, Inc. announced more than US$300 million in new commercial awards across gas, electric, and broader energy infrastructure services in the U.S. and Canada, mostly from new or expanded Master Services Agreements and new bid work. A key insight is that these awards lift Centuri’s year-to-date 2026 commercial wins to about US$1.70 billion and support an expected book-to-bill of roughly 1.2 times, highlighting solid conversion of its opportunity pipeline into...
NYSE:FDXF
NYSE:FDXFTransportation

US Stock Market Today: S&P 500 Futures Slide On Strong Jobs Data And Rate Jitters

The Morning Bull - US Market Morning Update Monday, Jun, 8 2026 US stock futures are pointing sharply lower this morning, with E mini S&P 500 contracts down about 2.6% and Nasdaq 100 futures off nearly 4.8%, as investors react to stronger than expected US jobs data and a jump in market volatility. Nonfarm payrolls rose by 172,000 in May and unemployment held at 4.3%, while wages grew 0.3% month over month, signaling a job market that is still firm and keeping alive the prospect of another...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

Is CoStar Group (CSGP) Attractive After A 57% Twelve Month Share Price Decline?

If you are wondering whether CoStar Group at around US$33.89 is starting to look like value or still overpriced, the key is to understand what the current share price actually reflects. The stock is roughly flat over the last 7 days at up 0.1% and up 3.4% over the last 30 days, but the longer term picture is much weaker with the share price down 48.4% year to date and down 57.1% over the last 12 months. These declines sit against a backdrop of ongoing attention on CoStar Group's role in real...
NasdaqGM:EMAT
NasdaqGM:EMATMetals and Mining

Assessing Evolution Metals & Technologies (EMAT) Valuation After Recent Share Price Weakness

Why Evolution Metals & Technologies stock is on investors’ radar Evolution Metals & Technologies (EMAT) has drawn attention after a recent pullback, with the stock down about 30% over the past month and roughly 19% over the past 3 months. With a market value near US$4.0b, revenue of US$1.879m and a net loss of about US$1.0b, the company’s focus on critical materials and advanced manufacturing comes amid ongoing share price pressure. See our latest analysis for Evolution Metals &...
NasdaqGS:QFIN
NasdaqGS:QFINConsumer Finance

Qfin Holdings (QFIN) Is Down 14.1% After Soft Q1 Results And Cautious Q2 Outlook - Has The Bull Case Changed?

Qfin Holdings, Inc. recently reported first-quarter 2026 results showing revenue of CNY 3,909.33 million and net income of CNY 883.32 million, alongside second-quarter net income guidance of RMB 830–910 million. The company also announced that board member Mr. Dan Zhao resigned for personal reasons on June 3, 2026, leaving an eight-person board with six independent directors overseeing its AI-driven credit-tech operations. We’ll now examine how Qfin’s weaker first-quarter earnings and...
NasdaqCM:PLSE
NasdaqCM:PLSEMedical Equipment

Assessing Pulse Biosciences (PLSE) Valuation After Strong Recent Share Price Momentum

Why Pulse Biosciences is on investors’ radar Pulse Biosciences (PLSE) has drawn fresh attention after a period of strong share price moves, including gains over the past month and past 3 months that stand out against its recent trading history. See our latest analysis for Pulse Biosciences. Against this backdrop, the recent 32.76% 30-day share price return and 30.23% 90-day share price return sit alongside an 89.17% year-to-date share price gain and a 3-year total shareholder return of...
NasdaqGS:NUVL
NasdaqGS:NUVLBiotechs

Does Nuvalent (NUVL) Have the Pipeline Depth to Justify Its Global Expansion Ambitions?

Nuvalent, Inc. recently announced that the U.S. FDA accepted New Drug Applications for its investigational lung cancer therapies neladalkib and zidesamtinib, granting Priority Review to neladalkib and setting target action dates of September 18 and November 27, 2026, respectively. Together with the appointment of Georg Pirmin Meyer, M.D., as Chief International Officer, these milestones highlight Nuvalent’s push to build a global commercial footprint around its late-stage oncology...
NYSE:NRGV
NYSE:NRGVElectrical

Energy Vault (NRGV) Is Up 8.3% After Accelerating Shift To Integrated Own-And-Operate Model

In recent developments, Energy Vault Holdings reported very large year-over-year revenue growth for fiscal 2025, driven by project execution in Australia and the U.S., the ramp-up of its Asset Vault portfolio, and US$450 million of new strategic financing, while shareholders reelected three Class II directors and ratified BDO USA, P.C. as auditor for the fiscal year ending December 31, 2026. Together, the rapid expansion of contracted capacity to 540 megawatts and the move into AI-focused...
NYSE:FPS
NYSE:FPSElectrical

Does Forgent Power Solutions' (FPS) Massive Equity Raise Hint At A Deeper Capital Structure Reset?

Forgent Power Solutions, Inc. recently completed a follow-on equity offering of approximately US$1.99 billion, issuing 42,280,000 Class A common shares at US$47 each, slightly below the reference price. This capital raise follows the company’s move to reprice its senior credit facilities and target lower interest costs, highlighting an active approach to reshaping its capital structure. We’ll now examine how this large equity raise, alongside the repriced credit facilities, may influence...
NYSE:ACA
NYSE:ACAConstruction

Barge Business Sale And Higher 2026 Targets Could Be A Game Changer For Arcosa (ACA)

Arcosa has completed the US$450 million sale of its barge business and, in its latest reported quarter, delivered 10% adjusted EBITDA growth with record results in utility structures while sharpening its focus on Construction Products and Engineered Structures. The company has also raised its full-year 2026 guidance for both revenue and adjusted EBITDA growth, highlighting how the streamlined portfolio and stronger cash generation are shaping its post-divestiture direction. We’ll now examine...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

If AI Healthcare Wins Big These Three Stocks Could Matter

With inflation readings, interest-rate expectations and energy prices all pulling investors in different directions, it can help to focus on clear, structural trends backed by real-world use cases. Artificial intelligence in healthcare fits that bill, with applications in diagnostics, personalised treatment, hospital efficiency and drug discovery already reshaping how care is delivered. Our Transformative AI Healthcare Stocks screener is designed to filter for companies directly exposed to...
NasdaqGS:OCFC
NasdaqGS:OCFCBanks

OceanFirst Merger And Warburg Capital Injection Reshape Growth And Governance

OceanFirst Financial (NasdaqGS:OCFC) has completed its merger with Flushing Financial, creating a larger combined bank. As part of the transaction, John R. Buran has been appointed non executive chairman of the expanded board. Warburg Pincus has invested $225 million through a private placement, adding fresh capital to the company. For investors tracking regional banks, OceanFirst Financial now looks very different from just a few months ago. The stock last closed at $18.14, with a return...
NasdaqCM:MVST
NasdaqCM:MVSTMachinery

Is Microvast (MVST) Facing a Deeper Governance Test After Its Accounting Chief’s Exit?

On May 27, 2026, Microvast Holdings, Inc. reported that Chief Accounting Officer Eric N. Garcia left the company, shortly before law firm Halper Sadeh LLC began investigating whether certain officers and directors breached fiduciary duties to shareholders. This combination of an accounting leadership change and a shareholder-focused legal review raises fresh questions about Microvast’s governance, oversight, and internal controls. Next, we’ll examine how the investigation into potential...